← Back

$ Value

$0

Shares

973

Price

$0

Filed

May 19

Insider

Name

DAWES KAREN A

Title

CIK

0001261506

Roles

Director

Transaction Details

Transaction Date

2025-05-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,096

Footnotes

Ms. Dawes was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. | Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Filing Info

Accession No.

0000950170-25-074251

Form Type

4

Issuer CIK

0000730272

DAWES KAREN A's History

Date Ticker Type Value
2025-06-10 BRNS A $0
2025-05-15 RGEN A $0
2025-05-15 RGEN A $0

Other Insiders at RGEN (90d)

Insider Bought Sold Last
Loeillot Olivier
Chief Executive Officer
$536K 2026-04-21